Model, data & replay
Native model and SBML branches, equations, pinned simulation environments, replay logs and properly labelled real, semi-synthetic or synthetic data.
Models you can audit and trust.
One versioned ZIP: executable model, data, reports, manuscripts, patent screens, due diligence and regulatory drafts, each file labelled by evidence status.
The exact contents are defined by the agreed brief. Optional and separately commissioned outputs are not automatically included.
From model files and provenance records to versioned simulations, checked analyses and scope-specific reports.
Native model and SBML branches, equations, pinned simulation environments, replay logs and properly labelled real, semi-synthetic or synthetic data.
Provenance, source and rights registers, rate-law and unit checks, validation records, uncertainty analysis and evidence-aware claim warnings.
Stage diligence records, risk registers, regulatory gap matrices and draft documents. Full due diligence reports and extension modules are separately commissioned.
Work can be scoped from intracellular and cellular models to tissue, organ, whole-body and whole-organism modelling.
Scaffold: The EHMN2027 intracellular and cellular model family is supplied separately, as stated in the product sheet.
The PDF details the folder structure, output library, manuscripts, patent and rights screening, decision-grade due diligence, lifecycle dossier and how to commission a model.
Define area, targets, drugs, endpoints, model family, evidence and licence. IQANOVA returns a scoped quote.